
BERLIN, April 17 (Reuters) - Bayer BAYGn.DE hopes to stem the costs of litigation over its weedkiller glyphosate by lobbying U.S. states to adjust their regulatory framework, the German chemicals company's CEO said in a draft speech released on Thursday.
"We are working towards this with lawmakers and gaining support beyond party lines," Chief Executive Bill Anderson said in a transcript of his speech for the company's annual shareholders' meeting on April 25.
Anderson said there was a risk that litigation could force Bayer to stop marketing glyphosate, adding: "We don't want that, but we have to prepare ourselves for all possible developments."